IDEAS home Printed from https://ideas.repec.org/p/chy/respap/143chedp.html
   My bibliography  Save this paper

Valuing health states: the effect of duration

Author

Listed:
  • Claire Gudex
  • Paul Dolan

Abstract

A central task in the field of health status measurement involves eliciting valuations for health states. When these valuations are then used in estimating patient benefit as part of a cost-utility analysis, a key issue is how the duration of a health state affects its value. Previous studies suggest that while people adapt to chronic illness over time there is a “maximal endurable time” beyond which the state becomes intolerable. The pilot study reported here examines the feasibility of using the visual analogue scale method to elicit within-respondent valuations for health states of different durations. It explores the hypothesis that while less severe states are seen as more acceptable the longer they last, more severe health states are seen as increasingly intolerable. 18 members of the general population ranked and rated 15 health states with durations of 1 month, 1 year and 10 years. The valuation given to a health state appeared to be a function of both its severity and its duration. The median score for a state lasting 10 years was lower when the same state lasted for 1 year or 1 month, supporting the concept of a “maximal endurable time”. Valuations for mild states did not, however, increase with duration.

Suggested Citation

  • Claire Gudex & Paul Dolan, 1995. "Valuing health states: the effect of duration," Working Papers 143chedp, Centre for Health Economics, University of York.
    • Handle: RePEc:chy:respap:143chedp
    as

    Download full text from publisher

    File URL: http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20143.pdf
    File Function: First version, 1995
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Stephen J Wright, 1986. "Age, sex and health: a summary of findings from the York Health Evaluation Survey," Working Papers 015chedp, Centre for Health Economics, University of York.
    2. George W. Torrance & Michael H. Boyle & Sargent P. Horwood, 1982. "Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States," Operations Research, INFORMS, vol. 30(6), pages 1043-1069, December.
    3. J. Leighton Read & Robert J. Quinn & Donald M. Berwick & Harvey V. Fineberg & Milton C. Weinstein, 1984. "Preferences for Health Outcomes," Medical Decision Making, , vol. 4(3), pages 315-329, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jose-Maria Abellan-Perpiñan & Jorge-Eduardo Martinez-Perez & Jose-Luis Pinto-Prades & Fernando-Ignacio Sanchez-Martinez, 2024. "Testing Nonmonotonicity in Health Preferences," Medical Decision Making, , vol. 44(1), pages 42-52, January.
    2. N J Devlin & P Hansen & P Kind & A H Williams, 2000. "The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs," Working Papers 180chedp, Centre for Health Economics, University of York.
    3. Nancy J. Devlin & Paul Hansen & Paul Kind & Alan Williams, 2003. "Logical inconsistencies in survey respondents' health state valuations ‐ a methodological challenge for estimating social tariffs," Health Economics, John Wiley & Sons, Ltd., vol. 12(7), pages 529-544, July.
    4. Irina Cleemput, 2010. "A social preference valuations set for EQ-5D health states in Flanders, Belgium," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(2), pages 205-213, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. David Parkin & Nancy Devlin, 2006. "Is there a case for using visual analogue scale valuations in cost‐utility analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 653-664, July.
    2. Raisa B. Deber & Vivek Goel, 1990. "Using Explicit Decision Rules to Manage Issues of Justice, Risk, and Ethics in Decision Analysis," Medical Decision Making, , vol. 10(3), pages 181-194, August.
    3. Cathleen Mooney & Alvin I. Mushlin & Charles E. Phelps, 1990. "Targeting Assessments of Magnetic Resonance Imaging in suspected Multiple sclerosis," Medical Decision Making, , vol. 10(2), pages 77-94, June.
    4. Zanakis, Stelios H. & Mandakovic, Tomislav & Gupta, Sushil K. & Sahay, Sundeep & Hong, Sungwan, 1995. "A review of program evaluation and fund allocation methods within the service and government sectors," Socio-Economic Planning Sciences, Elsevier, vol. 29(1), pages 59-79, March.
    5. Lee, Jonq-Ying & Rampersaud, Gail S. & Brown, Mark G., 2008. "An Index to Measure Health Status," Research papers 36819, Florida Department of Citrus.
    6. William B. Haskell & Wenjie Huang & Huifu Xu, 2018. "Preference Elicitation and Robust Optimization with Multi-Attribute Quasi-Concave Choice Functions," Papers 1805.06632, arXiv.org.
    7. George W. Torrance & David Feeny & William Furlong, 2001. "Visual Analog Scales," Medical Decision Making, , vol. 21(4), pages 329-334, August.
    8. Alan Shiell & Janelle Seymour & Penelope Hawe & Sue Cameron, 2000. "Are preferences over health states complete?," Health Economics, John Wiley & Sons, Ltd., vol. 9(1), pages 47-55, January.
    9. Brazier, John & Roberts, Jennifer & Deverill, Mark, 2002. "The estimation of a preference-based measure of health from the SF-36," Journal of Health Economics, Elsevier, vol. 21(2), pages 271-292, March.
    10. D. Stratmann‐Schoene & T. Kuehn & R. Kreienberg & R. Leidl, 2006. "A preference‐based index for the SF‐12," Health Economics, John Wiley & Sons, Ltd., vol. 15(6), pages 553-564, June.
    11. Holger J. Schünemann & Lauren Griffith & David Stubbing & Roger Goldstein & Gordon H. Guyatt, 2003. "A Clinical Trial to Evaluate the Measurement Properties of 2 Direct Preference Instruments Administered with and without Hypothetical Marker States," Medical Decision Making, , vol. 23(2), pages 140-149, March.
    12. A. David Paltiel & Kenneth A. Freedberg, 1998. "The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients," Interfaces, INFORMS, vol. 28(3), pages 34-51, June.
    13. Han Bleichrodt & Magnus Johannesson, 1997. "An Experimental Test of a Theoretical Foundation for Rating-scale Valuations," Medical Decision Making, , vol. 17(2), pages 208-216, April.
    14. Julie Chevalier & Gérard Pouvourville, 2013. "Valuing EQ-5D using Time Trade-Off in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 57-66, February.
    15. Arthur E. Attema & Han Bleichrodt & Olivier l’Haridon & Stefan A. Lipman, 2020. "A comparison of individual and collective decision making for standard gamble and time trade-off," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 465-473, April.
    16. Scott B. Cantor, 2004. "Clinical Applications in the Decision Analysis Literature," Decision Analysis, INFORMS, vol. 1(1), pages 23-25, March.
    17. Nick Bansback & Huiying Sun & Daphne P. Guh & Xin Li & Bohdan Nosyk & Susan Griffin & Paul G. Barnett & Aslam H. Anis, 2008. "Impact of the recall period on measuring health utilities for acute events," Health Economics, John Wiley & Sons, Ltd., vol. 17(12), pages 1413-1419, December.
    18. Barry Dewitt & Alexander Davis & Baruch Fischhoff & Janel Hanmer, 2017. "An Approach to Reconciling Competing Ethical Principles in Aggregating Heterogeneous Health Preferences," Medical Decision Making, , vol. 37(6), pages 647-656, August.
    19. Yelin Fu & Yubing Sui & Hao Luo & Biao Han, 2020. "Application of Social Choice Theory to Modify the Value Measure of Health Systems," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 148(3), pages 1005-1019, April.
    20. Mariëlle E.J.B. Goossens & Maureen P.M.H. Rutten‐Van Mölken & Ank M.J. Kole‐Snijders & Johan W.S. Vlaeyen & Gerard Van Breukelen & Reiner Leidl, 1998. "Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 39-51, February.

    More about this item

    Keywords

    health state valuation;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:chy:respap:143chedp. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Gill Forder (email available below). General contact details of provider: https://edirc.repec.org/data/chyoruk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.